5-hydroxytryptamine receptor 7 activity modulators and their method of use
US11192871B2 · kind B2 · utility
1Cited by
5References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 12, 2019 |
| Grant date | Dec 7, 2021 |
| Priority date | — |
| Expiry date | Dec 12, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.